Aspire Biopharma Holdings share price logo

Aspire Biopharma Holdings

NASDAQ: ASBP

$8.32

-0.38

(-4.37%)

as on

Aspire Biopharma Holdings Stock Performance

as on September 28, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $8.14
    $8.58
    downward going graph

    2.16%

    Downside

    3.12%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.31
    $562.92
    downward going graph

    60.23%

    Downside

    6665.87%

    Upside

    downward going graph

Aspire Biopharma Holdings share price movements today

Previous Close
$8.70
Open
$8.58
Volume
443.3K
Market Cap
$11.7M
Day's Low - High
$8.14 - $8.58
52 Week Low - High
$3.31 - $562.92

Aspire Biopharma Holdings Historical Returns

1 Month Return
-2.23 %
3 Month Return
+ 38.67 %
1 Year Return
-98.07 %
3 Year Return
0 %
5 Year Return
0 %

Aspire Biopharma Holdings Stock Fundamentals & Key Indicators

Check Aspire Biopharma Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.7M

EPS (TTM)

-8.02

Dividend Yield

0.00%

PE Ratio (TTM)

-1.04

Industry PE ratio

11.67

PEG Ratio

-0.006429166808524022

Return On Equity TTM

1993.26%

Aspire Biopharma Holdings Stock Valuation

Track how Aspire Biopharma Holdings P/E has moved over time to understand its valuation trends.

Aspire Biopharma Holdings in the last 5 years

  • Overview

  • Trends

Lowest (-392149.17x)

December 31, 2021

Today (-9.67x)

December 31, 2025

Industry (11.67x)

December 31, 2025

Highest (15633.30x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -9.67x

Aspire Biopharma Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aspire Biopharma Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$11.7MNA-1.0418.35%0.00%
NA$19.8BNA29.6714.58%1.82%
StrongBuy$69.7B110.7%27.1751.64%0.00%
Neutral$17.3B-15.11%23.8611.76%3.03%
StrongBuy$46.5B70.09%18.452.34%0.00%

Stock Returns calculator for Aspire Biopharma Holdings Stock including INR - Dollar returns

The Aspire Biopharma Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Aspire Biopharma Holdings investment value today

Current value as on today

₹2,088

Returns

-₹97,912

(-97.91%)

Returns from Aspire Biopharma Holdings Stock

-₹98,070 (-98.07%)

Dollar Impact

₹158 (+0.16%)

Indian Investors' Interest in Aspire Biopharma Holdings Stock

Search interest for Aspire Biopharma Holdings Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Aspire Biopharma Holdings Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
0
0
0
0
Gross Profit
-
-
-
-
-
-
0
0
0
0
Operating Income
-
0
0
0
-15
0
-1
-1
-1
-2
EBITDA
-2
1
0
0
-15
-1
1
4
0
-2
Interest Expense
0
0
-
0
0
0
1
6
1
-
Depreciation
-
-
-
-
-
-
2
5
1
-
Income Before Tax
-2
0
0
0
-15
-1
-1
-4
-3
-1
Income Tax Expense
-
-
0
-
-
-
-
-
-
-
Net Income
-2
0
0
0
-15
-1
-1
-4
-3
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
45.54%
-23.47%
20.28%
19.47%

Aspire Biopharma Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
0
Operating Income
0
0
-1
-1
-19
EBITDA
0
0
5
-1
-11
Interest Expense
-
-
0
0
8
Depreciation
0
-
1
-
8
Income Before Tax
0
3
4
-1
-24
Income Tax Expense
-
-
-
0
-
Net Income
0
3
4
-1
-24
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-1.87%

Aspire Biopharma Holdings Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
0
0
0
-15
-1
-1
-4
-3
-1
Operating Cash Flow
-2
0
-533
0
-1
-1
-1
0
-3
-2
Investing Cash Flow
-
13
38
-
-
-
-
-
-
-
Financing Cash Flow
2
-13
492
0
3
-
2
0
7
8
Change in Cash
-
-27
-3
0
1
-1
1
0
4
6

Aspire Biopharma Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
4
-1
-24
Operating Cash Flow
0
0
0
0
-4
Investing Cash Flow
-
-4
284
-
-
Financing Cash Flow
0
4
-284
0
5
Change in Cash
-
0
0
0
1

Mutual Funds that own Aspire Biopharma Holdings Stock

Check out the Mutual Funds with significant holdings in Aspire Biopharma Holdings.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.727742%
10207

Global Institutional Holdings in Aspire Biopharma Holdings

Funds
Holdings
Vanguard
0.74%
Fidelity Concord Street Trust
0.73%
Ken Fisher
0.71%

Insights on Aspire Biopharma Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ASBP stock has moved up by 38.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Knorr-Bremse AG American Depositary Receipts - Unsponsored Germany Federal Republic has given 21.2% return, outperforming this stock by 38.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Magna International has given 39.4% return, outperforming this stock by 137.5%

About Aspire Biopharma Holdings

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.
OrganisationAspire Biopharma Holdings
Headquarters23150 Fashion Drive, Estero, FL, 33928, US
IndustryBiotechnology
CEOKraig T. Higginson
E-voting on sharesClick here to vote

Key Management of Aspire Biopharma Holdings

Name

Title

Mr. Kraig T. Higginson

Interim CEO, President & Executive Chairman of the Board

Mr. Ernest J. Scheidemann Jr.

Chief Financial Officer

Mr. Stephen E. Quesenberry

General Counsel & Corporate Secretary

FAQs

What is Aspire Biopharma Holdings share price today?

Aspire Biopharma Holdings share price today is $8.32 as on at the close of the market. Aspire Biopharma Holdings share today touched a day high of $8.58 and a low of $8.14.

What is the 52 week high and 52 week low for Aspire Biopharma Holdings share?

Aspire Biopharma Holdings share touched a 52 week high of $562.92 on and a 52 week low of $3.31 on . Aspire Biopharma Holdings stock price today i.e. is closed at $8.32,which is 98.52% down from its 52 week high and 151.44% up from its 52 week low.

What is Aspire Biopharma Holdings's market capitalisation today?

Aspire Biopharma Holdings market capitalisation is $0.00T as on .

How to invest in Aspire Biopharma Holdings Stock (ASBP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aspire Biopharma Holdings on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aspire Biopharma Holdings Shares that will get you 0.1803 shares as per Aspire Biopharma Holdings share price of $8.32 per share as on September 28, 2026 at 8:46 am IST.

What is the minimum amount required to buy Aspire Biopharma Holdings Stock (ASBP) from India?

Indian investors can start investing in Aspire Biopharma Holdings (ASBP) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Aspire Biopharma Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on Aspire Biopharma Holdings share’s latest price of $8.32 as on September 28, 2026 at 8:46 am IST, you will get 1.2019 shares of Aspire Biopharma Holdings. Learn more about fractional shares .